Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

To compare the reporting on blinding in protocols and articles describing randomized controlled trials.We studied 73 protocols of trials approved by the scientific/ethical committees for Copenhagen and Frederiksberg, 1994 and 1995, and their corresponding publications.Three out of 73 trials (4%) reported blinding in the protocol that contradicted that in the publication (e.g., "open" vs. "double blind"). The proportion of "double-blind" trials with a clear description of the blinding of participants increased from 11 out of 58 (19%) when based on publications alone to 39 (67%) when adding the information in the protocol. The similar proportions for the blinding of health care providers were 2 (3%) and 22 (38%); and for the blinding of data collectors, they were 8 (14%) and 14 (24%). In 52 of 58 publications (90%), it was unclear whether all patients, health care providers, and data collectors had been blinded. In 4 of the 52 trials (7%), the protocols clarified that all three key trial persons had been blinded.The reporting on blinding in both trial protocols and publications is often inadequate. We suggest developing international guidelines for the reporting of trial protocols and public access to protocols.

Original publication

DOI

10.1016/j.jclinepi.2009.04.003

Type

Journal article

Journal

Journal of clinical epidemiology

Publication Date

09/2009

Volume

62

Pages

967 - 973

Addresses

The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark. ah@cochrane.dk

Keywords

Humans, Clinical Protocols, Double-Blind Method, Research Design, Publishing, Periodicals as Topic, Randomized Controlled Trials as Topic